Why the study?
Experimental evidence suggests metabolic syndrome is associated with changes in cardiac metabolism, but whether this occurs in humans is unknown.
Is the absence of myocardial 18F-FDG uptake associated with metabolic syndrome traits and early atherosclerosis in asymptomatic individuals?
Is the absence of myocardial 18F-FDG uptake associated with metabolic syndrome traits and early atherosclerosis in asymptomatic individuals?
In asymptomatic individuals, the absence of myocardial 18F-FDG uptake on PET-MR is a marker of cardiac insulin resistance and is associated with metabolic syndrome traits and early atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Absence of myocardial FDG uptake may mark cardiac insulin resistance; hypothesis-generating for PET-MR in asymptomatic metabolic risk assessment.
Devesa et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: